UCB, INC. v. ANNORA PHARMA PRIVATE LIMITED , No. 24-1056 (Fed. Cir. 2023)

Annotate this Case

Download PDF

Case: 24-1056 Document: 12 Page: 1 Filed: 11/21/2023 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ UCB, INC., UCB BIOPHARMA SRL, Plaintiffs-Appellees v. ANNORA PHARMA PRIVATE LIMITED, APOTEX INC., APOTEX CORP., Defendants MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD., Defendants-Appellants ______________________ 2024-1056 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00987-CFC-JLH, 1:20cv-01343-CFC, Chief Judge Colm F. Connolly. ______________________ ORDER The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b). Case: 24-1056 2 Document: 12 Page: 2 Filed: 11/21/2023 UCB, INC. V. ANNORA PHARMA PRIVATE LIMITED (2) Each side shall bear their own costs. FOR THE COURT November 21, 2023 Date /s/ Jarrett B. Perlow Jarrett B. Perlow Clerk of Court ISSUED AS A MANDATE: November 21, 2023

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.